Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. I-Mab
  6. News
  7. Sector news
    IMAB   US44975P1030

I-MAB

(IMAB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Pharmaceuticals
03:53aCOVID-19 Severity Appears Lower With Omicron, But High Hospitalization Volume Could Str..
MT
02:52aROCHE HOLDINGS AG : Goldman Sachs reiterates its Buy rating
MD
02:19aROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating
MD
01/25Drugmaker Teva fueled opioid addiction in New York, jury finds
RE
01/25Health Care Stocks Still Trying to Overcome Midday Slide
MT
01/25US Labor Department's OSHA Revokes COVID-19 Vaccination Order for Large Employers
MT
01/25Health Care Stocks Resisting Steeper Tuesday Market Losses
MT
01/25Pfizer, BioNTech Launch Clinical Study of Omicron-Specific COVID-19 Vaccine
MT
01/25Johnson & Johnson Posts Higher Fourth-Quarter Earnings; Sees COVID-19 Vaccine Sales of ..
MT
01/25Johnson & Johnson Forecasts COVID-19 Vaccine Sales Of Up To $3.5 Billion In 2022
MT
01/25Health Care Stocks Flat to Lower During Pre-Bell Tuesday
MT
01/25Berenberg Bank Adjusts AbbVie's Price Target to $115 From $105, Maintains Hold Rating
MT
01/25Stocks Point to Weaker Session as US Futures Retreat Pre-Bell; Europe Rises, Asia Tumbl..
MT
01/25Pfizer, BioNTech to Study Omicron-Based COVID-19 Vaccine in Adults
MT
01/25Pfizer, BioNTech Start Clinical Study On Omicron-based Vaccine
MT
01/25Genmab's Darzalex Sales Hit $6 Billion In 2021
MT
01/25Johnson & Johnson Q4 Adjusted EPS, Revenue Rise; Company Issues 2022 Outlook
MT
01/25Earnings Flash (JNJ) JOHNSON & JOHNSON Reports Q4 EPS $2.13, vs. Street Est of $2.12
MT
01/25Earnings Flash (JNJ) JOHNSON & JOHNSON Reports Q4 Revenue $24.8B, vs. Street Est of $25..
MT
01/25Wall Street Leans Back Pre-Bell; Futures Red, Europe Higher, Asia Lower
MT
01/25ANALYST RECOMMENDATIONS : AbbVie, Eli Lilly, Johnson & Johnson, Fox, United Airlines...
01/25Germany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1
RE
01/25Roche's Spinal Muscular Atrophy Drug Wins US FDA Priority Review
MT
01/25Roche Announces U.S. Food and Drug Administration Grants Evrysdi Priority Review for Tr..
CI
01/24Pfizer Urged To Ramp Up COVID-19 Pill Supply In Developing Countries, Aid Generics Entr..
MT
01/24US FDA Restricts Use of Eli Lilly, Regeneron's COVID-19 Treatments
MT
01/24U.S. FDA limits use of Regeneron, Lilly COVID-19 antibody treatments
RE
01/24Pfizer Inc. and BioNTech SE Publish Data from Two Laboratory Studies on Covid-19 Vaccin..
CI
01/24Health Care Stocks Declining This Afternoon
MT
01/24Health Care Stocks Dragged Lower in Broad-Based Equities Selloff
MT
01/24Chile to purchase 2 million Moderna COVID-19 vaccine doses
RE
01/24FDA to Restrict Monoclonal Antibodies Manufactured by Eli Lilly, Regeneron Pharmaceutic..
MT
01/24Roche Says Data Show Faricimab Improved Vision in Final-Stage Studies
MT
01/24Morgan Stanley Adjusts AbbVie's Price Target to $142 from $124, Keeps Overweight Rating
MT
01/24Morgan Stanley Adjusts Eli Lilly and Co.'s Price Target to $272 from $275, Keeps Overwe..
MT
01/24Morgan Stanley Adjusts Johnson & Johnson's Price Target to $175 from $187, Keeps Equalw..
MT
01/24EU Drug Regulator Reportedly Will Decide on Approval of Pfizer's COVID-19 Pill by End o..
MT
01/24Anixa Biosciences Says New COVID-19 Compound Shows Promise in Preliminary Lab Test
MT
01/24The Lancet Publishes Studies Showing Roche’s Faricimab Improved and Maintained Vis..
CI
01/24OPKO Health Shares Drop 20% After Complete Response Letter for Somatrogon
DJ
01/24Health Care Stocks Retreat Premarket Monday
MT
01/24Health Care
MT
01/24L3Harris Technologies Names Michelle Turner As CFO, Senior Vice President
MT
01/24EU Medicines Watchdog to Issue Decision on Pfizer's COVID-19 Pill in January
MT
01/24Oxford Says Mixed Vaccine Schedules Offer Strong Booster Responses After 2 Doses Of Cor..
RE
01/24EU regulator set to rule on Pfizer COVID pill by end-Jan, ahead of Merck
RE
01/24Pfizer-BioNTech Booster Shot Effective Against Omicron, New Study Finds
MT
01/24Israeli Study Finds Fourth Vaccine Dose Increases Resistance To COVID-19 In People Over..
MT
01/24Pfizer CEO Says Annual COVID-19 Vaccine Preferable Than Frequent Boosters
MT
01/24ROCHE HOLDINGS AG : JP Morgan remains Neutral
MD
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on I-MAB